Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 09:22 am Purchase | 2022-02-08 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 6,975,887 14.999% | 803,610 (+13.02%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | BlackRock Inc. BLK | 2,353,764 5.100% | 2,353,764 (New Position) | Filing History |
| 2021-08-10 10:33 am Purchase | 2021-08-09 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 6,172,277 13.873% | 6,172,277 (New Position) | Filing History |
| 2021-07-12 3:49 pm Purchase | 2021-06-28 | 13D | Monte Rosa Therapeutics, Inc. GLUE | New Enterprise Associates 17, L.P. | 7,694,916 17.300% | 7,694,916 (New Position) | Filing History |
| 2021-07-08 4:31 pm Purchase | 2021-06-28 | 13D | Monte Rosa Therapeutics, Inc. GLUE | Versant Venture Capital VI, L.P. | 6,799,115 15.300% | 6,799,115 (New Position) | Filing History |
| 2021-07-08 4:02 pm Purchase | 2021-06-28 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Cormorant Asset Management, LP | 3,193,974 7.180% | 3,193,974 (New Position) | Filing History |